TNFRSF4 and hepatocellular carcinoma: Recently, Kim et al33 demonstrated enhanced 4-1BB expression on CD8+ TIL from hepatocellular carcinoma (HCC) compared with expression of various other TNFRSF members (eg, GITR, TNFR2, HVEM, DR3, OX40, CD30).